Evidence map›Paper›PMID 33589715›Full record

ArticleScientific reports2021

Identification of sarcomatoid differentiation in renal cell carcinoma by machine learning on multiparametric MRI.

Asim Mazin, Samuel H Hawkins, Olya Stringfield, Jasreman Dhillon, Brandon J Manley, Daniel K Jeong, Natarajan Raghunand

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Diagnostic and prognostic role ofEJNMMI research · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Asim MazinDepartment of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Samuel H HawkinsDepartment of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Olya StringfieldIRAT Shared Service, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Jasreman DhillonDepartment of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Brandon J ManleyDepartment of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Daniel K JeongDepartment of Diagnostic & Interventional Radiology, Moffitt Cancer Center, Tampa, FL, 33612, USA.
Natarajan RaghunandDepartment of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. Natarajan.Raghunand@moffitt.org.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292NIH HHS P30 CA076292
6 · The paper itself

Abstract

Sarcomatoid differentiation in RCC (sRCC) is associated with a poor prognosis, necessitating more aggressive management than RCC without sarcomatoid components (nsRCC). Since suspected renal cell carcinoma (RCC) tumors are not routinely biopsied for histologic evaluation, there is a clinical need for a non-invasive method to detect sarcomatoid differentiation pre-operatively. We utilized unsupervised self-organizing map (SOM) and supervised Learning Vector Quantizer (LVQ) machine learning to classify RCC tumors on T2-weighted, non-contrast T1-weighted fat-saturated, contrast-enhanced arterial-phase T1-weighted fat-saturated, and contrast-enhanced venous-phase T1-weighted fat-saturated MRI images. The SOM was trained on 8 nsRCC and 8 sRCC tumors, and used to compute Activation Maps for each training, validation (3 nsRCC and 3 sRCC), and test (5 nsRCC and 5 sRCC) tumor. The LVQ classifier was trained and optimized on Activation Maps from the 22 training and validation cohort tumors, and tested on Activation Maps of the 10 unseen test tumors. In this preliminary study, the SOM-LVQ model achieved a hold-out testing accuracy of 70% in the task of identifying sarcomatoid differentiation in RCC on standard multiparameter MRI (mpMRI) images. We have demonstrated a combined SOM-LVQ machine learning approach that is suitable for analysis of limited mpMRI datasets for the task of differential diagnosis.

Indexed as

Diagnosis, DifferentialAlgorithmsCarcinoma, Renal CellCell DifferentiationFemaleHumansKidney NeoplasmsMachine LearningMaleMultiparametric Magnetic Resonance Imaging

Identifiers

PMID33589715
PMCPMC7884398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.